Atuka, 유전자 치료의 미래를 다룬 최신 백서 발간

We’re excited to share our latest white paper, The Future of Gene Therapy, authored by Dr. Patrick Howson, Chief Innovation Officer at Atuka.

Building on Atuka’s pioneering work in Parkinson’s disease and other neurodegenerative disorders, this paper lays out the transformative potential of gene therapy, covering critical advancements and future directions in the field. Lately, we have leveraged our expertise in rodent and NHP neuroanatomy and neurosurgery to become experts at delivering pharmacodynamic and biodistribution studies in the gene therapy area.

Whether you’re a researcher, clinician, pharmaceutical leader, or biotech enthusiast, Patrick provides valuable insights into the preclinical development of gene therapies, focusing on innovative delivery methods, regulatory landscapes, and evolving market dynamics.

Join us in exploring how gene therapy is revolutionizing medicine and offering new hope for countless patients worldwide.

• Advanced Delivery Systems: Explore the cutting-edge techniques improving gene therapy delivery, including rAAV vectors and non-viral platforms.
• Regulatory Challenges: Navigate the complex and fragmented regulatory landscape that gene therapies navigate.
• Market Insights: Understand the current market and future trends driving the growth of gene therapies.
• Preclinical Development: Learn about the crucial preclinical considerations, from species selection to immunogenicity and genomic risks.

백서 읽기.

Newsletter

Atuka의 최신 과학 연구 소식을 받아보세요

파킨슨병 연구의 최신 동향을 담은 분기별 뉴스레터를 받아보시려면 구독하세요.

메일링 리스트 등록

Talk to our experts

치료제 개발 프로그램을 성공으로 이끄세요